We narrowed to 856 results for: V2

1. API5-CRISPR

   Plasmid

   #157664

   Purpose

   Expresses Cas9 and sgRNA targeting API5

   Depositor

   Byung Il Lee

   Article

   Bong et al Nucleic Acids Res. 2020 Jun 19;48(11):63

   Insert

   Apoptosis inhibitor 5 (API5 Human)
   

   Use

   CRISPR and Lentiviral

   Expression

   Mammalian

   Available Since

   Aug. 20, 2020

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

2. pLenti-Puro-sgSIK3-A

   Plasmid

   #138682

   Purpose

   Expresses a mouse SIK3-targeting sgRNA and Cas9

   Depositor

   Reuben Shaw

   Article

   Hollstein et al Cancer Discov. 2019 Nov;9(11):1606-1627.

   Insert

   sgSIK3 mouse (Sik3 Mouse)
   

   Use

   Lentiviral

   Promoter

   hU6

   Available Since

   Feb. 26, 2020

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

3. pLenti-Puro-sgSIK3-C

   Plasmid

   #138683

   Purpose

   Expresses a mouse SIK3-targeting sgRNA and Cas9

   Depositor

   Reuben Shaw

   Article

   Hollstein et al Cancer Discov. 2019 Nov;9(11):1606-1627.

   Insert

   sgSIK3 mouse (Sik3 Mouse)
   

   Use

   Lentiviral

   Promoter

   hU6

   Available Since

   Feb. 20, 2020

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

4. pLentiCRISPR_puro_FAM136A_sg1

   Plasmid

   #244877

   Purpose

   Knockout of human FAM136A

   Depositor

   Alexis Jourdain

   Article

   Harhai et al Cell Rep. 2025 Jul 25;44(8):116069. doi:

   Insert

   FAM136A sgRNA (FAM136A Human)
   

   Use

   CRISPR and Lentiviral

   Promoter

   U6

   Available Since

   Oct. 15, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

5. pLentiCRISPR_puro_FAM136A_sg2

   Plasmid

   #244878

   Purpose

   Knockout of human FAM136A

   Depositor

   Alexis Jourdain

   Article

   Harhai et al Cell Rep. 2025 Jul 25;44(8):116069. doi:

   Insert

   FAM136A sgRNA (FAM136A Human)
   

   Use

   CRISPR and Lentiviral

   Promoter

   U6

   Available Since

   Oct. 15, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

6. pLentiCRISPR PARL sg1

   Plasmid

   #244853

   Purpose

   Knockout of human PARL

   Depositor

   Alexis Jourdain

   Article

   Harhai et al Cell Rep. 2025 Jul 25;44(8):116069. doi:

   Insert

   PARL sgRNA (PARL Human)
   

   Use

   CRISPR and Lentiviral

   Promoter

   U6

   Available Since

   Oct. 15, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

7. pLentiCRISPR PARL sg2

   Plasmid

   #244854

   Purpose

   Knockout of human PARL

   Depositor

   Alexis Jourdain

   Article

   Harhai et al Cell Rep. 2025 Jul 25;44(8):116069. doi:

   Insert

   PARL sgRNA (PARL Human)
   

   Use

   CRISPR and Lentiviral

   Promoter

   U6

   Available Since

   Oct. 15, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

8. pLentiCRISPR ATP23 sg1

   Plasmid

   #244847

   Purpose

   Knockout of human ATP23

   Depositor

   Alexis Jourdain

   Article

   Harhai et al Cell Rep. 2025 Jul 25;44(8):116069. doi:

   Insert

   ATP23 sgRNA (XRCC6BP1 Human)
   

   Use

   CRISPR and Lentiviral

   Promoter

   U6

   Available Since

   Oct. 15, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

9. pLentiCRISPR ATP23 sg2

   Plasmid

   #244848

   Purpose

   Knockout of human ATP23

   Depositor

   Alexis Jourdain

   Article

   Harhai et al Cell Rep. 2025 Jul 25;44(8):116069. doi:

   Insert

   ATP23 sgRNA (XRCC6BP1 Human)
   

   Use

   CRISPR and Lentiviral

   Promoter

   U6

   Available Since

   Oct. 15, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

10. pAG392

    Plasmid

    #226749

    Purpose

    CRISPRi guide RNA against ATP13A1

    Depositor

    Jonathan Weissman

    Article

    Guna et al Science. 2022 Oct 21;378(6617):317-322.

    Insert

    ATP13A1 (ATP13A1 Human)
    

    Use

    Lentiviral

    Available Since

    Oct. 24, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

11. pGM84

    Plasmid

    #220172

    Purpose

    CRISRPi guide RNA against BTF3

    Depositor

    Jonathan Weissman

    Article

    Muthukumar et al Mol Cell. 2024 Mar 21;84(6):1101-1119.e9

    Insert

    BTF3 (sgRNA) (BTF3 Human)
    

    Use

    Lentiviral

    Available Since

    June 7, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

12. pLentiCriprV2-sgRNA-PER1-#2

    Plasmid

    #189988

    Purpose

    Lentiviral Cas9/sgRNA vector targeting C-terminus of hPER1, works with Addgene 189979-189982

    Depositor

    Achim Kramer

    Article

    Gabriel et al Proc Natl Acad Sci U S A. 2024 Aug 20;12

    Insert

    Period1 (PER1 Human)
    

    Use

    CRISPR and Lentiviral

    Available Since

    Feb. 9, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

13. LENTICRISPR-LUC7L2_sgRNA1

    Plasmid

    #201602

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Article

    Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

    Insert

    LUC7L2 (LUC7L2 Human)
    

    Use

    CRISPR and Lentiviral

    Available Since

    Dec. 8, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

14. LENTICRISPR-PGM2_sgRNA2

    Plasmid

    #201617

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Article

    Skinner et al Nat Metab. 2023 May;5(5):765-776. doi: 1

    Insert

    PGM2 (PGM2 Human)
    

    Use

    CRISPR and Lentiviral

    Available Since

    July 26, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

15. LENTICRISPR-PGM2_sgRNA1

    Plasmid

    #201616

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Article

    Skinner et al Nat Metab. 2023 May;5(5):765-776. doi: 1

    Insert

    PGM2 (PGM2 Human)
    

    Use

    CRISPR and Lentiviral

    Available Since

    July 26, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

16. LENTICRISPR-UCK2_sgRNA2

    Plasmid

    #201633

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Article

    Skinner et al Nat Metab. 2023 May;5(5):765-776. doi: 1

    Insert

    UCK2 (UCK2 Human)
    

    Use

    CRISPR and Lentiviral

    Available Since

    July 26, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

17. LENTICRISPR-RPE_sgRNA2

    Plasmid

    #201619

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Article

    Skinner et al Nat Metab. 2023 May;5(5):765-776. doi: 1

    Insert

    RPE (RPE Human)
    

    Use

    CRISPR and Lentiviral

    Available Since

    July 17, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

18. LENTICRISPR-PFKM_sgRNA1

    Plasmid

    #201610

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Article

    Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

    Insert

    PFKM (PFKM Human)
    

    Use

    CRISPR and Lentiviral

    Available Since

    June 22, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

19. LENTICRISPR-PFKM_sgRNA2

    Plasmid

    #201611

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Article

    Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

    Insert

    PFKM (PFKM Human)
    

    Use

    CRISPR and Lentiviral

    Available Since

    June 22, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

20. LENTICRISPR-RPE_sgRNA1

    Plasmid

    #201618

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Article

    Skinner et al Nat Metab. 2023 May;5(5):765-776. doi: 1

    Insert

    RPE (RPE Human)
    

    Use

    CRISPR and Lentiviral

    Available Since

    June 22, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge